GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PharmaNutra SpA (FRA:761) » Definitions » Change In Receivables

PharmaNutra SpA (FRA:761) Change In Receivables : €-2.4 Mil (TTM As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is PharmaNutra SpA Change In Receivables?

PharmaNutra SpA's change in receivables for the quarter that ended in Dec. 2024 was €2.5 Mil. It means PharmaNutra SpA's Accounts Receivable declined by €2.5 Mil from Sep. 2024 to Dec. 2024 .

PharmaNutra SpA's change in receivables for the fiscal year that ended in Dec. 2024 was €-2.4 Mil. It means PharmaNutra SpA's Accounts Receivable increased by €2.4 Mil from Dec. 2023 to Dec. 2024 .

PharmaNutra SpA's Accounts Receivable for the quarter that ended in Dec. 2024 was €20.7 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. PharmaNutra SpA's Days Sales Outstanding for the three months ended in Dec. 2024 was 58.60.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. PharmaNutra SpA's liquidation value for the three months ended in Dec. 2024 was €-7.2 Mil.


PharmaNutra SpA Change In Receivables Historical Data

The historical data trend for PharmaNutra SpA's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaNutra SpA Change In Receivables Chart

PharmaNutra SpA Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.30 -1.09 -6.28 3.19 -2.41

PharmaNutra SpA Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.99 -6.44 2.18 -0.61 2.45

PharmaNutra SpA Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-2.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PharmaNutra SpA  (FRA:761) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

PharmaNutra SpA's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=20.738/32.291*91
=58.60

2. In Ben Graham's calculation of liquidation value, PharmaNutra SpA's accounts receivable are only considered to be worth 75% of book value:

PharmaNutra SpA's liquidation value for the quarter that ended in Dec. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=29.097-55.272+0.75 * 20.738+0.5 * 6.942
=-7.2

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PharmaNutra SpA Change In Receivables Related Terms

Thank you for viewing the detailed overview of PharmaNutra SpA's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmaNutra SpA Business Description

Traded in Other Exchanges
Address
Via Campodavela 1, Pisa, ITA, 56122
PharmaNutra SpA is a pharmaceutical company. The company is engaged in the research, design, development, and marketing of nutraceutical supplements and medical devices. The products of the company include SiderAL Folic, UltraMag, Cetilar, and others. The company operates in Europe, the Middle East, South America, the Far East, Asia and others.

PharmaNutra SpA Headlines

No Headlines